Cargando…

Adulteration of low‐delta‐9‐tetrahydrocannabinol products with synthetic cannabinoids: Results from drug checking services

Since late 2019, low‐delta‐9‐tetrahydrocannabinol (THC) preparations adulterated with synthetic cannabinoids (SCs) have been frequently observed in Switzerland. The unawareness of users concerning the presence of SCs and the typically higher potency and toxicity of SCs, when compared with THC, can r...

Descripción completa

Detalles Bibliográficos
Autores principales:	Monti, Manuela Carla, Zeugin, Jill, Koch, Konrad, Milenkovic, Natasa, Scheurer, Eva, Mercer‐Chalmers‐Bender, Katja
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2022
Materias:	Research Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9305195/ https://www.ncbi.nlm.nih.gov/pubmed/34997693 http://dx.doi.org/10.1002/dta.3220

Ejemplares similares

Phase I In Vitro Metabolic Profiling of the Synthetic Cannabinoid Receptor Agonists CUMYL-THPINACA and ADAMANTYL-THPINACA
por: Monti, Manuela Carla, et al.
Publicado: (2021)

Beyond Δ9-tetrahydrocannabinol and cannabidiol: chemical differentiation of cannabis varieties applying targeted and untargeted analysis
por: Monti, Manuela Carla, et al.
Publicado: (2022)

Quantitative determination of five cannabinoids in blood and urine by gas chromatography tandem mass spectrometry applying automated on‐line solid phase extraction
por: Frei, Priska, et al.
Publicado: (2022)

Effect of vaporizing cannabis rich in cannabidiol on cannabinoid levels in blood and on driving ability – a randomized clinical trial
por: Egloff, Laura, et al.
Publicado: (2023)

Phase I-metabolism studies of the synthetic cannabinoids PX-1 and PX-2 using three different in vitro models
por: Dahm, Patrick, et al.
Publicado: (2021)

Comparison of the Neurotoxic and Seizure-Inducing Effects of Synthetic and Endogenous Cannabinoids with Δ(9)-Tetrahydrocannabinol
por: Breivogel, Chris S., et al.
Publicado: (2020)

Acute induction of anxiety in humans by delta-9-tetrahydrocannabinol related to amygdalar cannabinoid-1 (CB1) receptors
por: Bhattacharyya, Sagnik, et al.
Publicado: (2017)

Delta-8 Tetrahydrocannabinol Product Impurities
por: Ray, Colleen L., et al.
Publicado: (2022)

Distribution of Synthetic Cannabinoids JWH-210, RCS-4 and ∆ 9-Tetrahydrocannabinol After Intravenous Administration to Pigs
por: Schaefer, Nadine, et al.
Publicado: (2017)

Mechanistic origin of partial agonism of tetrahydrocannabinol for cannabinoid receptors
por: Dutta, Soumajit, et al.
Publicado: (2022)

Heroin Adulterated with the Novel Synthetic Cannabinoid, 5F-MDMB-PINACA: A Case Series
por: Ershad, Muhammed, et al.
Publicado: (2020)

Cannabidiol binding and negative allosteric modulation at the cannabinoid type 1 receptor in the presence of delta-9-tetrahydrocannabinol: An In Silico study
por: Chung, Hery, et al.
Publicado: (2019)

Disruption of hippocampal synaptic transmission and long‐term potentiation by psychoactive synthetic cannabinoid ‘Spice’ compounds: comparison with Δ(9)‐tetrahydrocannabinol
por: Hoffman, Alexander F., et al.
Publicado: (2016)

Effect of Delta-9-Tetrahydrocannabinol on Mouse Resistance to Systemic Candida albicans Infection
por: Blumstein, Gideon W., et al.
Publicado: (2014)

Delta-9-tetrahydrocannabinol reduces willingness to exert effort in women
por: Wardle, Margaret C., et al.
Publicado: (2022)

The Diels‐Alder Approach towards Cannabinoid Derivatives and Formal Synthesis of Tetrahydrocannabinol (THC)
por: Hurrle, Thomas, et al.
Publicado: (2021)

Cognitive Impairment Induced by Delta9-tetrahydrocannabinol Occurs through Heteromers between Cannabinoid CB(1) and Serotonin 5-HT(2A) Receptors
por: Viñals, Xavier, et al.
Publicado: (2015)

Acute Effects of Delta-9-Tetrahydrocannabinol on Performance Monitoring in Healthy Volunteers
por: Spronk, Desirée, et al.
Publicado: (2011)

Affinity and Efficacy Studies of Tetrahydrocannabinolic Acid A at Cannabinoid Receptor Types One and Two
por: McPartland, John M., et al.
Publicado: (2017)

α-Glucosidase inhibitory activity of cannabidiol, tetrahydrocannabinol and standardized cannabinoid extracts from Cannabissativa
por: Suttithumsatid, Wiwit, et al.
Publicado: (2022)

Synthetic cannabinoids
por: Bilici, Rabia
Publicado: (2014)

Time- and temperature-dependent postmortem concentration changes of the (synthetic) cannabinoids JWH-210, RCS-4, as well as ∆9-tetrahydrocannabinol following pulmonary administration to pigs
por: Schaefer, Nadine, et al.
Publicado: (2020)

Descriptive Psychopathology of the Acute Effects of Intravenous Delta-9-Tetrahydrocannabinol Administration in Humans
por: Colizzi, Marco, et al.
Publicado: (2019)

A Conversion of Oral Cannabidiol to Delta9-Tetrahydrocannabinol Seems Not to Occur in Humans
por: Nahler, Gerhard, et al.
Publicado: (2017)

Glucocorticoids, Stress and Delta-9 Tetrahydrocannabinol (THC) during Early Embryonic Development
por: Kuzma-Hunt, Alexander G., et al.
Publicado: (2021)

Effects of Delta-9 Tetrahydrocannabinol (THC) on Oocyte Competence and Early Embryonic Development
por: Misner, Megan J., et al.
Publicado: (2021)

Transcriptional Alterations Induced by Delta-9 Tetrahydrocannabinol in the Brain and Gonads of Adult Medaka
por: Vassall, Marlee, et al.
Publicado: (2023)

Conversion of Cannabidiol (CBD) into Psychotropic Cannabinoids Including Tetrahydrocannabinol (THC): A Controversy in the Scientific Literature
por: Golombek, Patricia, et al.
Publicado: (2020)

In vitro evaluation of cell viability and expression profile of growth factors in mouse Sertoli cells exposed to Delta-9-tetrahydrocannabinol: a mechanistic insight into the cannabinoid-induced testicular toxicity
por: Mohammadpour-Asl, Shadi, et al.
Publicado: (2023)

Delta-9 tetrahydrocannabinol (THC) inhibits lytic replication of gamma oncogenic herpesviruses in vitro
por: Medveczky, Maria M, et al.
Publicado: (2004)

Disposable screen printed sensor for the electrochemical detection of delta-9-tetrahydrocannabinol in undiluted saliva
por: Wanklyn, Ceri, et al.
Publicado: (2016)

Delta-9-tetrahydrocannabinol, neural oscillations above 20 Hz and induced acute psychosis
por: Nottage, Judith F., et al.
Publicado: (2014)

Psychoactive drugs and false memory: comparison of dextroamphetamine and delta-9-tetrahydrocannabinol on false recognition
por: Ballard, Michael E., et al.
Publicado: (2011)

Delta-9-tetrahydrocannabinol and cannabidiol: Separating the chemicals from the “weed,” a pharmacodynamic discussion
por: Boggs, Douglas Lee, et al.
Publicado: (2016)

Delta-9-tetrahydrocannabinol increases striatal glutamate levels in healthy individuals: implications for psychosis
por: Colizzi, Marco, et al.
Publicado: (2019)

Antitumor Effects of Delta (9)-Tetrahydrocannabinol and Cannabinol on Cholangiocarcinoma Cells and Xenograft Mouse Models
por: Leelawat, Surang, et al.
Publicado: (2022)

Analgesia by intrathecal delta-9-tetrahydrocannabinol is dependent on Cav3.2 calcium channels
por: Gadotti, Vinicius de Maria, et al.
Publicado: (2023)

Self-reported adverse events associated with ∆(8)-Tetrahydrocannabinol (Delta-8-THC) Use
por: Leas, Eric C., et al.
Publicado: (2023)

Tetrahydrocannabinol (Delta 9-THC) Treatment in Chronic Central Neuropathic Pain and Fibromyalgia Patients: Results of a Multicenter Survey
por: Weber, Janet, et al.
Publicado: (2009)

Adulteration of Weight Loss Supplements by the Illegal Addition of Synthetic Pharmaceuticals
por: Jairoun, Ammar A., et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_dkbddmulvh8lch629ct9iio6ek